Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




EMKR, LXRX, EFJI, DrStockPick.com Watch List! for Friday November 13, 2009, EMCORE Corp., Lexicon Pharmaceuticals, Inc. and EF Johnson Technologies, Inc.

Dr. Stock Pick (November 12th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

DrStockPick.com Watch List!

My Picks for Friday November 13, 2009 are:

**************************************************************

EMKR, EMCORE Corporation

EMKR provides compound semiconductor-based components and subsystems for the broadband, fiber optic, satellite, and terrestrial solar power markets. EMKR is the world’s largest manufacturer of highly efficient radiation hard solar cells for space power applications.

** EMKR has been awarded a contract by Dutch Space of Leiden, The Netherlands to manufacture, test, and deliver the solar panels to power the Cygnus’ spacecraft being developed by Orbital Sciences Corporation for NASA’s Commercial Resupply Service project.

The total value of the contract would be in excess of $15 million.

More about EMKR

...
Tags for this Post:
3e Technologies, America, autoimmune disease, Biopharmaceutical, breakdown product, broadband, broker, carcinoid;, Commercial Resupply Service, conventional systems;, Crown Equity Holdings Inc.;, Cygnus, Diabetes, Dr Stock Pick, EF Johnson Technologies Inc;, Emcore Corp., equity trader, Federal Government, fiber optic, glaucoma, human disease, Investing Lessons, irritable bowel syndrome, Leiden, Lexicon Pharmaceuticals Inc.;, LX1031, Lxrx, National Aeronautics and Space Administration, Navy, Orbital Sciences Corporation for NASA, pain, professional investment analyst and consultant, quality secure communications solutions, semiconductor, space power applications, stock featured on our site;, Stock Pick, Stocks to Watch, The Netherlands, treatment of non-constipating irritable bowel syndrome, U.S. Department of Defense, United States Navy, USD, wireless sensor network solution, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.emcore.com, www.lexpharma.com, www.stock-ir.com

DrStockPick.com Stock Report! 9/15/09, LXRX, ALNY, EBAY, EMAN, IM, GELV

Dr. Stock Pick (September 15th, 2009) Writes:

DrStockPick.com Stock Report!

Tuesday September 15, 2009

signup3m

**************************************************************

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus. LX4211 is an orally-delivered, small molecule drug candidate that inhibits the sodium glucose transporter 2 (SGLT2). LX4211 is Lexicon’s fourth drug candidate currently being tested in Phase 2 clinical trials.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Medtronic, Inc. (NYSE: MDT),

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.